In this context, liquid biopsy, a method that has been widely investigated over the last decade [41], and neutrophil percentage-to-albumin ratio, which predicts mortality in bladder cancer patients [42], could be good tools to ascertain the reliability of the laboratory indices proposed, i.e., the TG/HDL ratio and PChE levels. The gene discussed is ALB; the disease is urinary bladder cancer.